Topline data were announced from two phase 3 trials evaluating MR-107A-02 for the treatment of moderate to severe acute pain.

A low dose combination hormonal patch was found to be effective for pregnancy prevention based on results from a phase 3 study.

Use of a combined oral contraceptive (COC) is not associated with asthma in women of reproductive age, but use of a progestogen-only pill (POP) is associated with an increased risk for asthma attacks ...

Individuals with type 2 diabetes or a higher BMI may face a reduced risk of developing GCA, while a history of cardiovascular disease may increase this risk.

The EULAR updated their recommendations for antirheumatic drug use among patients with RMDs during pregnancy and fertility ...

Patients with vs without RA have a higher risk for avoidable hospitalizations for ambulatory care sensitive conditions, particularly heart failure and pulmonary edema.

Metabolic syndrome is associated with elevated levels of pain catastrophizing among patients with PsA and may impact disease activity.

The use of HCQ among patients with SSc appears to be low and is not associated with improvements in hand function or activities of daily living.

Intracranial GCA appears to be more common than previously thought and is linked to higher rates of stroke and mortality.

Among children with Kawasaki disease, RDW-CV was identified as an independent predictor of CAD and was negatively correlated with markers of iron metabolism.

Results of the updated systematic review informing the 2024 EULAR recommendations showed that many ARDs are safe to use during pregnancy, lactation, and reproduction.

Osteoboost, a targeted vibration therapy device, is now available to improve bone strength and bone density in postmenopausal women.